Netherlands· NL-5d0bbc831803
Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg filmomhulde tabletten
A levodopa, decarboxylasehemmer und comt-hemmer product containing carbidopa 1-water + entacapone + levodopa, registered in Netherlands by Orion Corporation. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Levodopa, decarboxylasehemmer und comt-hemmer is registered in 12 of 19 countries.
Countries holding a registration under ATC N04BA03 (levodopa, decarboxylasehemmer und comt-hemmer), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Levodopa, decarboxylasehemmer und comt-hemmer · ATC N04BA03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of levodopa, decarboxylasehemmer und comt-hemmer costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), the median price runs from $1.36 in Italy to $5.49 in Switzerland — a ×4.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levodopa, decarboxylasehemmer und comt-hemmer · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.49
- IT Italy$1.36
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CARBIDOPA 1-WATER + ENTACAPONE + LEVODOPA
- Manufacturer
- Orion Corporation
- Country
- Netherlands (NL)
- ATC code
- N04BA03
- ATC class
- Levodopa, Decarboxylasehemmer und COMT-Hemmer
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/11/706
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for levodopa, decarboxylasehemmer und comt-hemmer.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levodopa, decarboxylasehemmer und comt-hemmer · interactions on record
158 records
- 4 severe
- 122 moderate
- 14 minor
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Methylthioninium chlorideV03AB17severe
18 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levodopa, decarboxylasehemmer und comt-hemmer in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCorbiltaOrion Corporation
- CzechiaLECIGIMONLobsor Pharmaceuticals AB, Uppsala
- FranceCORBILTA 75 mg/18,75 mg/200 mg, comprimé pelliculéORION CORPORATION
- IrelandCorbilta 100 mg/25mg/200 mg film coated tabletsOrion Corporation
- SwedenLecigon 20 mg/ml + 5 mg/ml + 20 mg/ml Intestinal gelLobSor Pharmaceuticals AB
- GermanyLecigonLobsor Pharmaceuticals Ab
- NorwayLecigonLobsor Pharmaceuticals AB
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Lecigimon, Trigelan
- Belgium · Lecigen
- Bulgaria · Лесигон
- Czechia · Lecigimon, Trigelan
- Germany · Lecigon, Levodopa/Carbidopa/Entacapon Abz
- Denmark · Lecigon, Levodopa/Carbidopa/Entacapone G.L. Pharma
- Estonia · Levodopa/Carbidopa/Entacapone Teva
- Spain · Lecigon
- Finland · Lecigon, Lecigon,
- France · Lecigimon, Levodopa/Carbidopa/Entacapone Teva
- United Kingdom (Northern Ireland) · Lecigon
- Greece · Levodopa+carbidopa+entacapone Mylan
- Croatia · Lecigon
- Hungary · Lecigon, Levodopa/Carbidopa/Entacapone Teva
- Ireland · Lecigon
- Italy · Lecigimon, Levodopa/Carbidopa/Entacapone Mylan
- Luxembourg · Lecigimon
- Latvia · Levodopa/Carbidopa/Entacapone Teva
- Norway · Lecigon
- Poland · Lecigon
- Portugal · Lecigon
- Romania · Lecigon, Levodopa/Carbidopa/Entacaponă Teva
- Sweden · Lecigon, Levodopa/Carbidopa/Entacapone Pharmexon
- Slovenia · Lecigon
- Slovakia · Lecigon, Trigelan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfc91fd0-8636-42fb-ab77-73f500649c0f GET /v1/drugs/dfc91fd0-8636-42fb-ab77-73f500649c0f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/levodopa/carbidopa/entacapone-orion-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Levodopa, Decarboxylase Inhibitor And Comt Inhibitor",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp109830",
"excipients": [
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROL 85 PER CENT (E 422)",
"HYPROMELLOSE (E 464)",
"IJZEROXIDE ROOD (E 172)",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"MAÏSZETMEEL",
"POLYSORBAAT 80 (E 433)",
"POVIDON (E 1201)",
"SACCHAROSE",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"CARBIDOPA 1-WATER",
"ENTACAPONE",
"LEVODOPA"
],
"leaflet_url": null,
"authorised_at": "2011/08/25",
"procedure_number": "EMEA/H/C/002441",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/11/706",
"additional_monitoring": "N"
}See everything about levodopa, decarboxylasehemmer und comt-hemmer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.